Today’s Research Reports on Trending Tickers: Geron Corporation and Array BioPharma Inc.
NEW YORK, NY / ACCESSWIRE / March 26, 2018 / Rising concerns over a potential trade war with China continued to drag markets down on Friday, with the Dow Jones plummeting more than 400 points. The Dow Jones Industrial Average dropped 1.77 percent to close at 23,533.20, while the S&P 500 Index fell 2.10 percent to close at 2,588.26. The Nasdaq Composite Index declined 2.43 percent to close at 6,992.67.
"There was plenty of good news this morning: durable goods and the signing of the spending bill, but investors could not shake off uncertainty created by the Trump administration when it comes to trade with China," said Erin Browne, head of asset allocation at UBS Asset Management.
RDI Initiates Coverage on:
Geron Corporation
https://rdinvesting.com/news/?ticker=GERN
Array BioPharma Inc.
https://rdinvesting.com/news/?ticker=ARRY
Geron Corporation's stock jumped 7.22% Friday, to close the day at $5.64. The stock recorded a trading volume of 27,572,706 shares, which was above its three months average volume of 4,889,224 shares. In the last year, Geron Corporation's shares have traded in a range of 1.74 - 6.68. The share price has gained 224.14% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.88 is greater than its 200-day moving average of $2.26. Shares of Geron Corporation have gained roughly 152.91 percent in the past month and are up 213.33 percent year-to-date.
Access RDI's Geron Corporation Research Report at:
https://rdinvesting.com/news/?ticker=GERN
On Friday, shares of Array BioPharma Inc. recorded a trading volume of 2,289,724 shares, which was below the three months average volume of 3,892,663 shares. The stock ended the day 0.92% higher at 16.50. The share price has gained 145.17% from its 52-week low with a 52-week trading range of 6.73 - 18.78. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $17.29 is greater than its 200-day moving average of $13.25. Shares of Array BioPharma Inc. have fallen roughly 9.09 percent in the past month and are up 28.91 percent year-to-date.
Access RDI's Array BioPharma Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ARRY
Our Actionable Research on Geron Corporation (NASDAQ:GERN) and Array BioPharma Inc. (NASDAQ:ARRY) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
